SUPER-1 evaluated GZR4 in insulin-naïve Chinese adults with T2DM, while SUPER-2 assessed those previously treated with basal insulin.

The potential health impacts of low-to-moderate alcohol intake appear to vary by beverage type, according to a study ...

The US Food and Drug Administration (FDA) is considering whether to allow new ingredients in dietary supplements. The move could eventually expand the range of products marketed for things like muscle ...

Relutrigine, a novel sodium channel modulator, is under FDA Priority Review for the treatment of pediatric SCN2A and SCN8A epileptic encephalopathies.

People residing in Birmingham, Alabama, recently learned that their drinking water would no longer contain fluoride. But there was a bigger surprise. It turns out fluoride had already been removed ...

In terms of locoregional recurrence, risk remains low when patients are treated with RT tailored to their individual risk.

An outbreak of E. coli linked to raw milk and cheese has now sickened 9 people, including several young kids, health ...

Alongside the approval of Ponlimsi, the FDA is reviewing a BLA for TEV-45779, a biosimilar candidate for Xolair, covering all ...

Lirafugratinib, an oral FGFR2 inhibitor, receives FDA Priority Review for advanced cholangiocarcinoma with FGFR2 ...

Elegrobart is a subcutaneously-administered monoclonal antibody designed to target and inhibit the IGF-1 receptor, a key driver of thyroid eye disease.

This high dose nusinersen regimen for spinal muscular atrophy includes 50mg loading doses and 28mg maintenance doses.

More recently, the nomination of Dr Casey Means, the White House’s pick for surgeon general, has also stalled, mostly due to concerns about previous vaccine statements. What’s more, the CDC is also ...